Marc-Andre Laplante
Overview
Explore the profile of Marc-Andre Laplante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
de Champlain J, Wu R, Girouard H, Karas M, El Midaoui A, Laplante M, et al.
Clin Exp Hypertens
. 2005 Feb;
26(7-8):593-601.
PMID: 15702613
Several experimental and clinical evidences have linked an enhanced production of reactive oxygen species (ROS) to certain diseases of the cardiovascular system including hypertension and diabetes. However, it has never...
12.
Laplante M, Wu R, Moreau P, de Champlain J
Free Radic Biol Med
. 2005 Feb;
38(5):589-96.
PMID: 15683715
Angiotensin II and endothelin-1 (ET) are two hormones involved in cardiovascular diseases and well known for their capacity to induce free radical generation in vascular and cardiac tissues. In addition...
13.
Wu R, Laplante M, de Champlain J
J Hypertens
. 2004 May;
22(4):793-801.
PMID: 15126922
Background: Angiotensin II (Ang II)-induced oxidative stress has been suspected to play an important part in the pathogenesis of many cardiovascular diseases. Our previous study demonstrated that acetylsalicylic acid (ASA)...
14.
Laplante M, Wu R, El Midaoui A, de Champlain J
J Hypertens
. 2003 Apr;
21(5):927-36.
PMID: 12714867
Objective: To determine whether the activation of nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase and the increase of superoxide anion production by angiotensin II is dependent upon the activation of the...
15.
Millette E, Demeilliers B, Wu R, Laplante M, El Midaoui A, Moreau P, et al.
J Hypertens
. 2003 Jan;
21(1):125-35.
PMID: 12544444
Objective: To compare the cardiovascular protection provided by omapatrilat and lisinopril in an experimental model of hypertension. Methods: Four-week deoxycorticosterone acetate (DOCA)-salt hypertensive (HT) and age-matched normotensive (NT) rats were...